Inspire Veterinary Partners Files 8-K with Material Agreement

TL;DR

IVP filed an 8-K on 10/21 for a material definitive agreement. Big news coming.

AI Summary

Inspire Veterinary Partners, Inc. announced on October 21, 2024, that it entered into a material definitive agreement. The company also disclosed information related to Regulation FD and filed financial statements and exhibits as part of this 8-K filing.

Why It Matters

This filing indicates a significant development for Inspire Veterinary Partners, Inc., likely involving a new contract or partnership that could impact its business operations and financial performance.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the lack of specific details in this initial filing warrants a medium risk assessment.

Key Players & Entities

• INSPIRE VETERINARY PARTNERS, INC. (company) — Registrant
• October 21, 2024 (date) — Date of earliest event reported
• Nevada (jurisdiction) — State of incorporation
• 001-41792 (commission_file_number) — SEC File Number
• 85-4359258 (irs_number) — I.R.S. Employer Identification No.
• 780 Lynnhaven Parkway , Suite 400 Virginia Beach , VA 23452 (address) — Address of principal executive offices
• ( 757 ) 734-5464 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.0001 — ch registered Common stock, par value $0.0001 IVP Nasdaq Capital Market Indicat
• $0.25 — rrants"), at a public offering price of $0.25 per Share or Pre-paid Warrant. The Sha
• $25,000 — of the gross proceeds, reimbursement of $25,000 in non-accountable expenses, and up to
• $75,000 — in non-accountable expenses, and up to $75,000 in legal fees and out-of-pocket expense
• $2,500,000 — fees and other offering expenses, were $2,500,000. The Company intends to use the proceed

Filing Documents

• ea0218343-8k_inspire.htm (8-K) — 30KB
• ea021834301ex5-1_inspire.htm (EX-5.1) — 9KB
• ea021834301ex10-1_inspire.htm (EX-10.1) — 170KB
• ea021834301ex10-2_inspire.htm (EX-10.2) — 83KB
• ea021834301ex99-1_inspire.htm (EX-99.1) — 10KB
• ex5-1_001.jpg (GRAPHIC) — 13KB
• ex99-1_001.jpg (GRAPHIC) — 16KB
• 0001213900-24-089739.txt ( ) — 587KB
• ivp-20241021.xsd (EX-101.SCH) — 3KB
• ivp-20241021_lab.xml (EX-101.LAB) — 33KB
• ivp-20241021_pre.xml (EX-101.PRE) — 22KB
• ea0218343-8k_inspire_htm.xml (XML) — 4KB

01 Entry Into a Material Definitive

Item 1.01 Entry Into a Material Definitive Agreement On October 21, 20924, Inspire Veterinary Partners, Inc., a Nevada corporation (the "Company"), entered into Securities Purchase Agreements under which the Company agreed to sell to the investors named therein, in a best efforts public offering (the "Offering"), an aggregate of 1,800,000 shares of the Company's Class A Common Stock, par value $0.0001 per share (the "Shares") and pre-paid warrants to purchase 8,200,000 shares of Class A Common Stock (the "Pre-paid Warrants"), at a public offering price of $0.25 per Share or Pre-paid Warrant. The Shares and Pre-paid Warrants were offered by the Company pursuant to a registration statement on Form S-3, as amended (File No. 333-282355), filed with the Securities and Exchange Commission (the "Commission"), which was declared effective by the Commission on October 11, 2024 (the "Registration Spartan Capital Securities, LLC ("Spartan") acted as the sole placement agent for the Offering and received a fee of 8% of the gross proceeds, reimbursement of $25,000 in non-accountable expenses, and up to $75,000 in legal fees and out-of-pocket expenses, pursuant to a letter of engagement between the Company and Spartan. Gross proceeds from the Offering, before deducting the placement agent's fees and other offering expenses, were $2,500,000. The Company intends to use the proceeds of the Offering for working capital, general corporate purposes, and potential additional future acquisitions. Section 7 – Regulation FD

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On October 22, 2024, we released the press release furnished herewith as Exhibit 99.1. Section 9 – Financial Statements and Exhibits Item. 9.01. Financial Statements and Exhibits. Exhibit No. Description 5.1 Opinion of The Crone Law Group, P.C. 10.1 Form of Securities Purchase Agreement 10.2 Form of Pre-paid Warrant 23.1 Consent of The Crone Law Group, P.C. (included in Exhibit 5.1) 99.1 Press Release regarding pricing of the offering 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 22, 2024 INSPIRE VETERINARY PARTNERS, INC. By: /s/ Kimball Carr Name: Kimball Carr Title: President and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR